Decoding Liver Fibrosis: How Omics Technologies and Innovative Modeling Can Guide Precision Medicine
International Journal of Molecular Sciences · 15.03.2025 · 26 (6) · 2658
DOI: 10.3390/ijms26062658 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.03.2025. Verfasst von Gabriele Codotto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science and Biotechnology, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Liver Cirrhosis, Precision Medicine, Genomics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: QuB - Quantum Behavior in Biological Function funded by MUR, QuB—Quantum Behavior in Biological Function funded by MUR, Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy.
Abstract (Originalsprache)
The burden of chronic liver disease (CLD) is dramatically increasing. It is estimated that 20–30% of the population worldwide is affected by CLD. Hepatic fibrosis is a symptom common to all CLDs. Although it affects liver functional activities, it is a reversible stage if diagnosed at an early stage, but no resolutive therapy to contrast liver fibrosis is currently available. Therefore, efforts are needed to study the molecular insights of the disease. Emerging cutting-edge fields in cellular and molecular biology are introducing innovative strategies. Spatial and single-cell resolution approaches are paving the way for a more detailed understanding of the mechanisms underlying liver fibrosis. Cellular models have been generated to recapitulate the in-a-dish pathophysiology of liver fibrosis, yielding remarkable results that not only uncover the underlying molecular mechanisms but also serve as patient-specific avatars for precision medicine. Induced pluripotent stem cells (iPSC) and organoids are incredible tools to reshape the modeling of liver diseases, describe their architecture, and study the residents of hepatic tissue and their heterogeneous population. The present work aims to give an overview of innovative omics technologies revolutionizing liver fibrosis research and the current tools to model this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Science and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.
- AREA Science Park, 34149 Trieste, Italy.
- Department of Life Science, University of Trieste, 34127 Trieste, Italy.
- Fondazione Italiana Fegato ONLUS-Italian Liver Foundation NPO, 34149 Trieste, Italy.
ORCID-Profile: Gabriele Codotto, Claudio Tiribelli, Cristina Bellarosa
Förderung
- QuB - Quantum Behavior in Biological Function funded by MUR
- QuB—Quantum Behavior in Biological Function funded by MUR
- Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy
Zitieren
APA
Codotto, G., Blarasin, B., Tiribelli, C., Bellarosa, C., & Licastro, D. (2025). Decoding Liver Fibrosis: How Omics Technologies and Innovative Modeling Can Guide Precision Medicine. International Journal of Molecular Sciences, 26(6), 2658. https://doi.org/10.3390/ijms26062658
Vancouver
Codotto G, Blarasin B, Tiribelli C, Bellarosa C, Licastro D. Decoding Liver Fibrosis: How Omics Technologies and Innovative Modeling Can Guide Precision Medicine. International Journal of Molecular Sciences. 2025;26(6):2658. doi:10.3390/ijms26062658
BibTeX
@article{Codotto2025,
author = {Codotto, Gabriele and Blarasin, Benedetta and Tiribelli, Claudio and Bellarosa, Cristina and Licastro, Danilo},
title = {Decoding Liver Fibrosis: How Omics Technologies and Innovative Modeling Can Guide Precision Medicine},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {6},
pages = {2658},
doi = {10.3390/ijms26062658}
}
EUVIMED